Literature DB >> 29940921

Run4Love, a mHealth (WeChat-based) intervention to improve mental health of people living with HIV: a randomized controlled trial protocol.

Yan Guo1,2,3, Y Alicia Hong4, Jiaying Qiao5, Zhimeng Xu6, Hanxi Zhang7,8,9, Chengbo Zeng7,8,9, Weiping Cai7,8,9, Linghua Li5, Cong Liu6, Yiran Li6, Mengting Zhu6, Nathan Asher Harris9, Cui Yang6.   

Abstract

BACKGROUND: People living with HIV (PLWH) suffer from high rates of mental illness; but targeted effective interventions are limited, especially in developing countries. High penetration of smartphone usage and widespread acceptance of social media applications provide an unprecedented opportunity for mobile-based health interventions (mHealth interventions) in resource-limited settings like China. The current report describes the design and sample characteristics of the Run4Love randomized controlled trial (RCT) aimed at improving mental health in PLWH in China.
METHODS: A total of 300 PLWH with elevated depressive symptoms were recruited and randomized into either the intervention or control group. Participants in the intervention group received an adapted cognitive-behavioral stress management (CBSM) course delivered by the enhanced WeChat platform (for 3 months) and were motivated to engage in physical activities. Progress of the participants was automatically tracked and monitored with timely feedback and rewards. The control group received a brochure on nutrition for PLWH in addition to standard care. The outcome assessments are conducted at baseline, 3, 6, and 9 months using tablets. The primary outcome is depressive symptoms measured by the scale of the Center for Epidemiology Studies Depression (CES-D). Secondary outcomes include quality of life, chronic stress measured with biomarker of hair cortisol, and other measures of stress and depression, self-efficacy, coping, HIV-related stigma, physical activity, and patient satisfaction. Mixed effects model with repeated measures (MMRM) will be used to analyze the intervention effects. DISCUSSION: The Run4Love study is among the first efforts to develop and evaluate a multicomponent and integrated mHealth intervention to improve the mental health and quality of life of PLWH. Once proven effective, Run4Love could be scaled up and potentially integrated into the routine case management of PLWH and adapted to other populations with chronic diseases. TRIAL REGISTRATION: Chinese Clinical Trial Registry - ChiCTR-IPR-17012606 , registered on 07 September 2017.

Entities:  

Keywords:  Depression; Mental health; People living with HIV (PLWH); Randomized controlled trial; mHealth intervention

Mesh:

Year:  2018        PMID: 29940921      PMCID: PMC6019517          DOI: 10.1186/s12889-018-5693-1

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


Background

People living with HIV (PLWH) are among those at high risk of mental illness, because of stigma associated with the disease and the groups with higher risks of infection and transmission of HIV [1]. Elevated mental health problems may lead to serious negative impacts on PLWH, including deteriorated immune system, worsened disease progression, and increased risky behaviors such as non-adherence to medication, inconsistent condom use, drug abuse, and suicide [2-7]. While life expectancy of PLWH has been vastly improved thanks to the development of anti-retroviral treatments, few effective interventions exist to improve mental health status of PLWH, especially in middle- and low-income countries, where more than 90% of PLWH live. Therefore, an urgent need exists for the development and evaluation of interventions to improve mental health status and quality of life for PLWH [8]. An estimated 758,000 PLWH live in China; similar to other middle- and low-income countries, the limited healthcare resources could not meet the increasing needs of PLWH for mental health services [9]. Only 20,000 certified mental health professionals practice in China, meaning 1.5 per 100,000 people, around 1/10 of the ratio in the US [10]. As a result of such limited resource of mental health service, only 8% of people with mental disorder ever sought professional help [11]. For PLWH, the stigma surrounding their conditions was much more severe and fewer have ever received any treatment or care for mental health issues. More than 95% of the Chinese adults own a mobile phone [12]. Such high coverage mobile access provides an unprecedented opportunity for mobile-based health (mHealth) interventions [13]. With over 900 million active users in 2017, WeChat is the most popular instant communication app and a de facto part of daily lives of most Chinese people [14]. Existing mHealth intervention studies in developed countries have shown feasibility and efficacy of improving mental health in different populations [15-19]. However, mHealth interventions for PLWH have mostly been focused on improving medication adherence, with limited data on their feasibility and efficacy to improve mental health of PLWH [20-22]. Moreover, existing mHealth studies were mostly pre-post designs without a control group or had small sample sizes; there is a lack of mHealth interventions with a rigorous design of randomized controlled trial (RCT) [17]. To address this literature gap, we developed the mHealth intervention “Run4Love” based on our pilot study and relevant literature. To the best of our knowledge, the Run4Love program is one of the first WeChat-based, multi-model mHealth interventions to improve mental health and quality of life of PLWH.

Methods

Overall study design

This intervention was designed for PLWH with elevated depressive symptoms. Eligible patients who provided informed consent were enrolled and, after a baseline interview and hair sample collection, randomized to the Run4Love intervention group or the waitlist control group. The intervention consists of information sending, monitoring, and timely feedback via the enhanced WeChat platform. Outcome assessments are conducted at baseline, 3, 6, and 9 months in the clinic. The 3-month assessment interval directly parallels the interval period between clinic visits by the participants. The primary outcome is depressive symptoms measured by the Center for Epidemiological Studies Depression Scale (CES-D). Secondary outcomes include quality of life, chronic stress (measured by hair cortisol), other depression and stress measurements, self-efficacy, coping, HIV-related stigma, physical activity, and patient satisfaction. The intervention protocol was approved by the Institutional Review Board at the Sun Yat-Sen University, and the study protocol has been registered in chictr.org.cn (number ChiCTR-IPR-17012606).

Participation eligibility

The participation eligibility criteria were: 1) 18 years or older, 2) HIV seropositive, 3) having elevated depressive symptoms (CES-D ≥ 16), 4) willing to provide hair samples, and 5) using WeChat. Individuals were excluded if they: 1) were using psychiatric drugs, 2) had hair permed or dyed in the past 3 months, 3) were unable to finish the questionnaire due to mental or other illnesses or other reasons; 4) were unable to read or listen to the materials sent via WeChat (i.e., short articles, audios, posters); or 5) were unable to engage in physical activities due to medical reasons.

Recruitment and randomization

Participants were recruited from the outpatient clinic of the only hospital designated for HIV treatment in Guangzhou, the third largest city in China. Patients waiting to see a physician were invited by the research staff to complete a brief screening questionnaire. Those who met the eligibility criteria were given a pamphlet with description of the Run4Love study and invited to join the study. Patients with interest to participate would receive further information about the study in a private room. After providing the written informed consent, eligible patients completed a baseline survey on a tablet and provided their hair samples. Allocation to treatment group was carried out by a computer-generated randomization list with block size of 4 using SAS software version 9.4 (SAS Institute, Inc., Cary, NC, USA). Study participants were reimbursed 50 RMB (about 8 US dollars) or gifts of equivalent value for each of the study interviews completed (baseline and 3 follow-up interviews) and continued to receive all their standard HIV medical care.

Intervention protocol

Participants in the intervention group received a 3-month mHealth intervention of the Run4Love, consisting of the following two major components: the adapted cognitive-behavioral stress management (CBSM) course and regular physical activity promotions delivered by our enhanced WeChat platform. We created a public account of Run4Love to deliver CBSM information; additional functions of automatic tracking of information reception and physical activity and instant feedback were added. Only participants in the intervention group could receive information from the Run4Love account. The four major components of the Run4Love protocol are detailed below.

Cognitive-behavioral stress management course

The cognitive-behavioral stress management (CBSM) course, an evidence-based intervention to improve mental health of PLWH was adapted for the Chinese PLWH on the social media platform of WeChat [23, 24]. Our bilingual research staff translated the content of CBSM; extensive formative research was conducted to ensure its cultural relevance. The program was piloted and further refined before its delivery. The final program consists of 9 sessions and 3 review sessions for a total length of 12 weeks (3 months); see Table 1 for details of adaption and program outlines.
Table 1

The adapted 9-session Cognitive-Behavioral Stress-Management (CBSM) course

SessionContentWeek
Session 1Introduction to the program and stressors and stress responses1
Audio Progressive muscle relaxation for 16 muscle groups
Session 2Stress and awareness2
Audio Progressive muscle relaxation for 8 muscle groups
Session 3Negative thinking and cognitive distortions3
Audio Breathing, imagery, passive progressive muscle relaxation for 4 muscle groups
Review 1Review and course evaluation of session 1, 2, and 34
Session 4Anxiety and depression5
Audio Breathing, imagery, passive progressive muscle relaxation
Session 5Rational thought replacement6
Audio Autogenic training for heaviness and warmth
Session 6Productive coping and executing effective coping responses7
Audio Autogenic training for heartbeat, breathing, abdomen, and forehead
Review 2Review and course evaluation of session 4, 5, and 68
Session 7Introduction of meditation9
Audio Autogenic training with imagery and self-suggestions
Session 8Anger management10
Audio Mantra meditation
Session 9Social support and review of the program11
Audio Imagery and meditation
Review 3Review and course evaluation of all sessions12
The adapted 9-session Cognitive-Behavioral Stress-Management (CBSM) course

Physical activity promotion

The second major component of the Run4Love program was the promotion of regular physical activity. Information about the benefits of regular exercise, how to exercise safely and effectively, and healthy dietary information was sent via the Run4Love account on a weekly basis. One week after the recruitment, we called the participants to confirm their enrollment and assisted them to set goals for weekly physical activities (e.g., walk 8000 steps a day). They also learned to adjust their exercise routine based on personalized feedback sent via WeChat.

Automatic progress monitoring

Participants receive CBSM and physical activity promotion information (including audio, pictures, and short essays) on their WeChat account 3–4 times a week based on the time slots they selected. The Run4Love platform could trace the frequency of reading or listening to each file. Based on frequency analysis, the most popular files would be repeatedly sent in the next 3 months post-intervention. Participants’ daily steps are also automatically tracked by the WeChat platform so we could send them instant and personalized feedback. Each week, based on their progress, we sent their weekly feedback with small incentives (e.g., red packet with small amount of money) via WeChat, see Fig. 1 for a sample interface of Run4Love platform.
Fig. 1

WeChat users’ interfaces in the Run4Love study

WeChat users’ interfaces in the Run4Love study

Social support

Participants in the intervention group also received up to 5 phone calls from the research staff at one week, 1, 2, 5, and 8 months after enrollment. The phone call in the first week was for confirming participation and ensuring participants’ proper use of the system. The purposes of the phone calls are: 1) to provide feedback on participants’ mental health status based on their monthly quick assessment on WeChat; 2) to evaluate participants’ progress and help identify barriers, as well as to aid in finishing CBSM and engaging in regular physical activities; 3) to prevent and identify adverse events during the intervention and take appropriate actions; and 4) to provide reminders of their regular medical check-ups.

Control group

Participants in the waitlist control group received a brochure on nutrition and healthy living in addition to standard care for HIV treatment. Our pilot study found that PLWH were quite concerned with their physical health conditions, and that nutrition information was well received by them. Participants in the control group would receive the Run4Love intervention after the completion of the trial.

Outcome measures and data collection procedure

Table 2 summarizes the outcome measures, measurement variables/scales, internal reliability (Cronbach’s coefficient alpha) of the scales, and assessment times of the current study. Participants’ demographics, psychosocial outcomes, and satisfaction with the program would be collected with surveys on tablets. The primary outcome is depressive symptoms assessed at 3-month follow-up; it is measured by the Center for Epidemiological Studies Depression Scale (CES-D), Chinese version [25]. CES-D assesses participants’ mood in the past week, with 20 items measuring 4 dimensions (i.e., positive affect, depressed affect, interpersonal relationship, and somatic and retarded activity). The Cronbach alpha of the scale is 0.9. The scores of CES-D range from 0 to 60, with scores≥16 being considered as having elevated depressive symptoms and higher scores indicating more severe depressive symptoms.
Table 2

Measures and schedule of Run4Love outcome assessments

Schedule
DomainMeasureItemsAlphaa0 mo1 mo2 mo3 mo6 mo9 mo
DemographicsAge, gender, height, weight, education, sexual orientation, marital status, employment, daily expenses affordability, HIV infection duration10n/aX
DepressionCenter for Epidemiological Studies Depression Scale (CES-D)b200.90XXXX
Patient Health Questionnaire (PHQ-9)c90.86XXXXXX
Physical activityGlobal Physical Activity Questionnaire (GPAQ)d160.85XXXX
Quality of LifeWorld Health Organization Quality of Life HIV short version (WHOQOL-HIV BREF)e310.85XXXX
Self-efficacyGeneral Self-efficacy Scale (GSES)f100.87XXXX
StressPerceived Stress Scale (PSS)g100.83XXXX
Hair cortisol (biomarker)n/an/aXX
HIV-related stigmaHIV Stigma Scaleh14XXXX
*Internalized stigma (8 items)0.92
*Perceived stigma (6 items)0.90
CopingSimplified Ways of Coping Questionnaire (SWCQ)i20XXXX
*Positive coping (12 items)0.89
*Negative coping (6 items)0.78
SatisfactionIntervention-specific satisfaction20n/aX

aCronbach’s coefficient alpha for internal reliability of the scale; n/a = not applicable

bCES-D scores range 0–27; higher scores indicate more severe depressive symptoms

cPHQ-9 scores range 0–60; higher scores indicate more severe depressive symptoms

dGPAQ uses Metabolic equivalents (METs) to measure the intensity of physical activities; higher METs indicate more intensive physical activities

eWHOQOL-HIV BREF scores range 24–120; higher scores indicate better quality of life

fGSES scores range 0–40; higher scores indicate better self-efficacy

gPSS scores range 0–40; higher scores indicate more stress

hHIV Stigma Scale scores range 14–56; higher scores indicate more HIV-related stigma

iSWCQ scores range 0–36 for positive coping and 0–24 for negative coping; higher scores indicate higher levels of coping

Measures and schedule of Run4Love outcome assessments aCronbach’s coefficient alpha for internal reliability of the scale; n/a = not applicable bCES-D scores range 0–27; higher scores indicate more severe depressive symptoms cPHQ-9 scores range 0–60; higher scores indicate more severe depressive symptoms dGPAQ uses Metabolic equivalents (METs) to measure the intensity of physical activities; higher METs indicate more intensive physical activities eWHOQOL-HIV BREF scores range 24–120; higher scores indicate better quality of life fGSES scores range 0–40; higher scores indicate better self-efficacy gPSS scores range 0–40; higher scores indicate more stress hHIV Stigma Scale scores range 14–56; higher scores indicate more HIV-related stigma iSWCQ scores range 0–36 for positive coping and 0–24 for negative coping; higher scores indicate higher levels of coping Secondary outcomes include quality of life, chronic stress (measured by hair cortisol), physical activity, other depression and stress measurements, self-efficacy, coping, HIV-related stigma, and patient satisfaction. Quality of life is assessed by World Health Organization Quality of Life HIV short version (WHOQOL-HIV BREF), with 31 items measuring 6 domains (i.e., physical, psychological, level of independence, social relationships, environment, and beliefs) [26]. The scores of WHOQOL-HIV BREF range from 24 to 120 with a higher score representing a higher level of quality of life. As a biomarker of chronic stress, hair samples are collected by research staff at baseline and the immediate follow-up after 3-month intervention. Following the procedure detailed by Veldhorst and colleagues, approximately 100 pieces of hairs from each participant are cut from the posterior vertex of the scalp, wrapped by tin foil, and stored at − 20 degrees Celsius temperature in fridge [27]. A commercially available enzyme-linked immunosorbent assay kit for salivary cortisol will be used to assess hair cortisol concentration for chronic stress. Higher levels of hair cortisol concentration indicate higher levels of chronic stress [28-30]. Physical activity is measured by the Chinese version of Global Physical Activity Questionnaire (GPAQ) that is widely used in people with chronic diseases [31]. Metabolic equivalents (METs) calculated from GPAQ measure the intensity of physical activities with METs≥600 representing that individuals meet the minimum requirement of WHO recommendation of weekly exercises intensity. We also collected other psychosocial outcomes including the depression scale of Patient Health Questionnaire (PHQ-9) and Perceived Stress Scale (PSS) [32, 33]. The cut-off point for depression is 10 in PHQ-9 with higher scores indicating higher levels of depression. Self-efficacy is measured by 10-item General Self-efficacy Scale (GSES), Chinese version [34]. The total scores of GSES range 10–40 with higher scores indicating higher self-efficacy. Coping is assessed with Simplified Ways of Coping Questionnaire (SWCQ), Chinese version, with 20 items (scores 0–60) measuring 2 domains (i.e., positive and negative coping) [35]. HIV-related stigma is assessed by 14 items derived from the HIV Stigma Scale measuring internalized and perceived stigma [36, 37] with higher scores representing higher levels of stigma. Patient satisfaction will also be assessed with 20 items measuring general and intervention specific satisfaction, which will be collected in the follow-up surveys [38].

Statistical considerations

Sample size justification

The sample size was calculated based on the primary outcome of depressive symptoms measured by CES-D. Effect size is widely used to measure treatment effects of continuous outcomes, calculated as the difference between groups divided by the pooled standard deviation [39]. A prior study of online intervention to treat depression using CES-D as the primary outcome reported the effect size of 0.57 [40]. Effect sizes of 0.2 and 0.5 are typically considered as the cut-off points for small and moderate effects [39]. To ensure enough sample size to detect moderate treatment effect, we hypothesized a conservative effect size of 0.4. Assuming α = 0.05, β = 0.15, and allowing for up to 20% attrition, the sample size of 282 is needed for the current study. Thus the 300 participants we recruited for this RCT were sufficient to detect the hypothesized effect size.

Statistical analysis

Baseline sample characteristics will be compared between the intervention and control groups using analyses of variance (ANOVA) for normally-distributed continuous variables, Wilcoxon tests for non-normally-distributed continuous variables, and Chi-square tests for categorical variables. Analyses of outcomes are based on intention-to-treat strategy for all randomized participants. For the primary outcome, group differences in CES-D scores over the 9 months of the trial will be estimated using mixed effects model repeated measures (MMRM) analysis, adjusting for baseline CES-D score and time [41]. As we collect data using a tablet during each interview, every question in the electronic questionnaire is required, so missing data is minimized. For respondents missing one or more interviews, MMRM allows data from completed interviews to be retained for analyses. For sensitivity analyses, group differences will also be compared using last-observation carried forward (LOCF) imputation for all outcomes [42]. A similar approach will be conducted to examine group differences in the secondary outcomes such as HIV-related quality of life and chronic stress shown in Table 2. Analyses on secondary outcomes will not be adjusted for multiple comparisons. Instead, results from secondary outcomes will be interpreted with caution unless they reach a high level of statistical significance (P < 0.001). Analyses will be performed using SAS Version 9.4 (SAS Institute, Cary, North Carolina).

Baseline characteristics

Figure 2 shows the process of participant screening, eligibility determination, and enrollment conducted from September to December 2017. A total of 1555 PLWH were screened, with 538 having elevated depressive symptoms (CES-D ≥ 16). Twenty-four of the 538 patients were not interested in eligibility interview; 164 were eligible but not interested in the trial; and 50 were not eligible after further screening. Finally, 300 eligible patients consented and were enrolled; they were randomized to the intervention or control group. Randomization resulted in comparable groups on all variables except for sexual orientation (Table 3). Overall, the sample had a median age of 27.5 years (IQR: 24.5–51.3) and a median body mass index (BMI) of 20.1; the majority (92.3%) were men, well-educated (60.7% with at least some college education), unmarried (87.3%), employed (83.7%), with adequate income (85%), and most (81.7%) had sexual orientation of homosexual, bisexual, or uncertain. The participants had a median duration of HIV infection since diagnosis of 1.72 years (IQR: 0.59–3.71).
Fig. 2

Flowchart of Run4Love intervention trial

Table 3

Baseline characteristics of 300 participants enrolled in the Run4Love study

Total (n = 300)Intervention (n = 150)Control (n = 150)
Age in years, median (Q1,Q3)27.5 (24.5, 31.3)27.4 (24.3, 31.1)27.8 (24.6, 32.2)
Sex, % men92.394.790.0
BMI, median (Q1,Q3)20.1 (18.6, 21.7)20.2 (18.7, 21.9)19.9 (18.6, 21.3)
Education, % > high school60.765.365.0
Homosexual/bisexual/uncertain,%81.786.776.7
Married, %12.712.013.3
Employed, %83.782.085.3
Daily expenses, % affordable85.086.084.0
Infection period in years,Median (Q1,Q3)1.7 (0.6, 3.7)1.7 (0.6,4.0)1.8 (0.6,3.6)
CES-D [0–60],Median (Q1,Q3)23.0 (19.0, 28.0)23 (19.0, 28.0)23 (19.0, 27.0)
PHQ-9 depression [0–27]Median (Q1,Q3)10.0 (7.0, 13.0)10.0 (7.0, 12.8)10.0 (7.0, 13.0)
GPAQ physical activity (METs),% ≥60043.343.343.3
HIV-related quality of life [24–120], Mean ± Standard deviation77.0 ± 9.277.4 ± 9.076.6 ± 9.4
GSES Self efficacy [10–40],Median (Q1,Q3)23.0 (20.0, 27.2)23.0 (20.0, 28.0)23.0 (20.0, 27.0)
Perceived stress [0–40],Median (Q1,Q3)20 (18, 23)20 (17, 22)20 (18, 23)
HIV-related Stigma [14–56],Median (Q1,Q3)38.0 (32.0, 42.0)37.0 (32.0, 42.0)38.0 (34.0, 42.0)
Positive coping [0–36],Median (Q1,Q3)18 (14, 22)18 (14, 21)18 (13.2, 22)
Negative coping [0–24],Median (Q1,Q3)12 (9, 15)12 (9, 15)12 (9, 15)
CD4, median (Q1,Q3)413 (304, 534)416 (309, 536)405 (303, 522)
Flowchart of Run4Love intervention trial Baseline characteristics of 300 participants enrolled in the Run4Love study At baseline, the median score of CES-D was 23 (IQR: 19–28), representing moderate to severe level of depression (cut-off point for severe depression being 24). The median score of PHQ-9 was 10.0 (IQR: 7.0–13.0), meaning half of the participants reached clinical significance of depression. Perceived stress was 20 (IQR: 18–23), with the majority (85.3%) of the participants reporting moderate stress, 8.5% severe stress, and 6.3% mild stress. Less than half (43.3%) of the participants had met the WHO recommendations on physical activities with METs≥600. There was no significant difference between the intervention and control group in terms of psychological outcomes and physical activities (Table 3).

Discussion

The Run4Love study achieved the targeted enrollment of 300 PLWH with elevated depressive symptoms. Most participants were willing to participate in the study. There was no significant difference in the CES-D scores between PLWH who were eligible but not interested and those enrolled in the study. Randomization resulted in comparable intervention and control groups in all measures except sexual orientation. Important innovations of the Run4Love study include the development of an enhanced WeChat platform, the multi-model intervention design, and testing hair cortisol as a biomarker of chronic stress. The enhanced WeChat platform was developed with the functions to automatically distribute multi-media intervention materials, track participants’ progress with those materials, and provide timely feedback. The Run4Love study has two major components: the CBSM program and physical activity promotions, coupled with timely feedback provided both automatically by the enhanced platform and by research staff, with both messages of encouragement and financial incentives. The Run4Love study is adaptable and suitable for resource-limited settings with constrained mental health services and has the potential to be scaled up. As the number of people living with chronic conditions has increased in recent years and chronic diseases account for more than 80% of deaths in China, the experience learned from the Run4Love study will also be valuable to manage other chronic conditions and reduce healthcare cost in society [43]. There are several limitations in the Run4Love study. First, all participants were recruited from one hospital in a large city, thus the sample might not be representative of the PLWH population in China, especially those from rural areas, or whose HIV seropositive status was unknown, or those not on HIV treatment. However, the recruitment site is the only hospital designated for HIV treatment in Guangzhou metropolitan area, serving more than 100,000 HIV/AIDS patients in the region. Second, the participants consist of mostly young men who have sex with men (MSM), which may be due to the fact that young MSM are better educated and more likely to accept a mHealth intervention. Further, existing studies have revealed that HIV seropositive MSM are more likely to experience depression and have a dire need for targeted mental health intervention [44]. Third, a potential self-report bias exists as most outcomes are measured using self-report scales. However, our RCT design could limit such bias, plus the biomarker of chronic stress measured by hair cortisol could provide more objective measurement. The Run4Love study is among the first efforts to innovatively develop and test a social media-based mHealth intervention to improve psychological well-being and quality of life in PLWH. Once proven effective, Run4Love could be potentially integrated into the routine case management of PLWH. An intervention like Run4Love could also be adapted and tailored to other populations with chronic diseases where depression is prevalent (e.g., cancer survivors, postpartum women with depression). The follow-ups are currently ongoing and we will report the intervention effects when the follow-ups conclude.
  35 in total

Review 1.  Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions.

Authors:  Evan Russell; Gideon Koren; Michael Rieder; Stan Van Uum
Journal:  Psychoneuroendocrinology       Date:  2011-10-04       Impact factor: 4.905

2.  Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users.

Authors:  Julia H Arnsten; Xuan Li; Yuko Mizuno; Amy R Knowlton; Marc N Gourevitch; Kathleen Handley; Kelly R Knight; Lisa R Metsch
Journal:  J Acquir Immune Defic Syndr       Date:  2007-11-01       Impact factor: 3.731

3.  Evaluating the effectiveness and efficacy of unguided internet-based self-help intervention for the prevention of depression: a randomized controlled trial.

Authors:  Ove K Lintvedt; Kathleen M Griffiths; Kristian Sørensen; Andreas R Østvik; Catharina E A Wang; Martin Eisemann; Knut Waterloo
Journal:  Clin Psychol Psychother       Date:  2011-09-02

4.  Measuring stigma in people with HIV: psychometric assessment of the HIV stigma scale.

Authors:  B E Berger; C E Ferrans; F R Lashley
Journal:  Res Nurs Health       Date:  2001-12       Impact factor: 2.228

5.  Mobile health in China: current status and future development.

Authors:  Huijun Li; Tianhong Zhang; Hongmei Chi; Yingmei Chen; Yue Li; Jijun Wang
Journal:  Asian J Psychiatr       Date:  2014-06-24

Review 6.  The impact of mental health and substance abuse factors on HIV prevention and treatment.

Authors:  James Walkup; Michael B Blank; Jeffrey S Gonzalez; Steven Safren; Rebecca Schwartz; Larry Brown; Ira Wilson; Amy Knowlton; Frank Lombard; Cynthia Grossman; Karen Lyda; Joseph E Schumacher
Journal:  J Acquir Immune Defic Syndr       Date:  2008-03-01       Impact factor: 3.731

7.  Validation of the Chinese general self-efficacy scale among individuals with schizophrenia in Hong Kong.

Authors:  Frank P F Chiu; Hector W H Tsang
Journal:  Int J Rehabil Res       Date:  2004-06       Impact factor: 1.479

8.  The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy.

Authors:  Lawrence Mbuagbaw; Lehana Thabane; Pierre Ongolo-Zogo; Richard T Lester; Edward J Mills; Marek Smieja; Lisa Dolovich; Charles Kouanfack
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

9.  Hair Measurements of Cortisol, DHEA, and DHEA to Cortisol Ratio as Biomarkers of Chronic Stress among People Living with HIV in China: Known-Group Validation.

Authors:  Shan Qiao; Xiaoming Li; Samuele Zilioli; Zheng Chen; Huihua Deng; Juxian Pan; Weigui Guo
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

10.  Depression and HIV risk among men who have sex with men in Tanzania.

Authors:  Hycienth Ahaneku; Michael W Ross; Joyce E Nyoni; Beatrice Selwyn; Catherine Troisi; Jessie Mbwambo; Adeniyi Adeboye; Sheryl McCurdy
Journal:  AIDS Care       Date:  2016
View more
  15 in total

1.  Long-term Effects of a Social Media-Based Intervention (Run4Love) on Depressive Symptoms of People Living With HIV: 3-Year Follow-up of a Randomized Controlled Trial.

Authors:  Yan Guo; Yingqi Li; Chuanchuan Yu; He Xu; Y Alicia Hong; Xiaolan Wang; Nanxiang Zhang; Yu Zeng; Aliza Monroe-Wise; Linghua Li; Cong Liu; Weiping Cai; Aihua Lin
Journal:  J Med Internet Res       Date:  2022-06-28       Impact factor: 7.076

2.  Effects of a Mobile Health Intervention to Promote HIV Self-testing with MSM in China: A Randomized Controlled Trial.

Authors:  Xiaofang Zhu; Wenhan Zhang; Don Operario; Yue Zhao; Anxia Shi; Zhihua Zhang; Pan Gao; Ashley Perez; Jun Wang; Nickolas Zaller; Cui Yang; Yehuan Sun; Hongbo Zhang
Journal:  AIDS Behav       Date:  2019-11

3.  Public Knowledge about Dementia in China: A National WeChat-Based Survey.

Authors:  Dan Liu; Guirong Cheng; Lina An; Xuguang Gan; Yulian Wu; Bo Zhang; Sheng Hu; Yan Zeng; Liang Wu
Journal:  Int J Environ Res Public Health       Date:  2019-10-31       Impact factor: 3.390

4.  A Men Who Have Sex With Men-Friendly Doctor Finder Hackathon in Guangzhou, China: Development of a Mobile Health Intervention to Enhance Health Care Utilization.

Authors:  Chunyan Li; Yuan Xiong; Hao Fong Sit; Weiming Tang; Brian J Hall; Kathryn E Muessig; Chongyi Wei; Huanyu Bao; Shufang Wei; Dapeng Zhang; Guodong Mi; Fei Yu; Joseph D Tucker
Journal:  JMIR Mhealth Uhealth       Date:  2020-02-27       Impact factor: 4.773

5.  Mechanisms and Effects of a WeChat-Based Intervention on Suicide Among People Living With HIV and Depression: Path Model Analysis of a Randomized Controlled Trial.

Authors:  Yiran Li; Yan Guo; Y Alicia Hong; Mengting Zhu; Chengbo Zeng; Jiaying Qiao; Zhimeng Xu; Hanxi Zhang; Yu Zeng; Weiping Cai; Linghua Li; Cong Liu
Journal:  J Med Internet Res       Date:  2019-11-27       Impact factor: 5.428

6.  Mediators of Intervention Effects on Depressive Symptoms Among People Living With HIV: Secondary Analysis of a Mobile Health Randomized Controlled Trial Using Latent Growth Curve Modeling.

Authors:  Mengting Zhu; Weiping Cai; Linghua Li; Yan Guo; Aliza Monroe-Wise; Yiran Li; Chengbo Zeng; Jiaying Qiao; Zhimeng Xu; Hanxi Zhang; Yu Zeng; Cong Liu
Journal:  JMIR Mhealth Uhealth       Date:  2019-11-15       Impact factor: 4.773

7.  Dose-Response Effects of Patient Engagement on Health Outcomes in an mHealth Intervention: Secondary Analysis of a Randomized Controlled Trial.

Authors:  Yiran Li; Yan Guo; Y Alicia Hong; Yu Zeng; Aliza Monroe-Wise; Chengbo Zeng; Mengting Zhu; Hanxi Zhang; Jiaying Qiao; Zhimeng Xu; Weiping Cai; Linghua Li; Cong Liu
Journal:  JMIR Mhealth Uhealth       Date:  2022-01-04       Impact factor: 4.773

8.  Effect of a WeChat-Based Intervention (Run4Love) on Depressive Symptoms Among People Living With HIV in China: A Randomized Controlled Trial.

Authors:  Yan Guo; Y Alicia Hong; Weiping Cai; Linghua Li; Yuantao Hao; Jiaying Qiao; Zhimeng Xu; Hanxi Zhang; Chengbo Zeng; Cong Liu; Yiran Li; Mengting Zhu; Yu Zeng; Frank J Penedo
Journal:  J Med Internet Res       Date:  2020-02-09       Impact factor: 5.428

9.  The Evaluation of the Effect of ICT in HIV Prevention in the General Population in China Based on an Information-Motivation-Behavioral Skill Model.

Authors:  Xia Liang; Jun Yang; Abu S Abdullah; Zhikui He; Li Yang
Journal:  Biomed Res Int       Date:  2020-10-29       Impact factor: 3.411

10.  Relationship Between Patient Engagement and Depressive Symptoms Among People Living With HIV in a Mobile Health Intervention: Secondary Analysis of a Randomized Controlled Trial.

Authors:  Yu Zeng; Yan Guo; Linghua Li; Y Alicia Hong; Yiran Li; Mengting Zhu; Chengbo Zeng; Hanxi Zhang; Weiping Cai; Cong Liu; Shaomin Wu; Peilian Chi; Aliza Monroe-Wise; Yuantao Hao; Rainbow Tin Hung Ho
Journal:  JMIR Mhealth Uhealth       Date:  2020-10-29       Impact factor: 4.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.